In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intersect Follows Leaders In ENT

Executive Summary

Following the lead of ENT start-ups like Acclarent and Entellus Medical, Intersect ENT Inc. is introducing a line of stent like implants capable of performing the same role drug-eluting stents played in interventional cardiology. Intersect’s implants provide moderate structural support to tissue that has been cut or dilated through FESS or balloon sinuplasty. But the principal function of the implant isn’t propping open nasal passageways but rather delivering drugs. A trio of clinical studies conducted by the company has found the released steroids produced statistically significant reductions in inflammation, polyp formation, and postoperative adhesions.

Advertisement

Related Content

People Briefs: Owens & Minor, Laurimed, Xagenic, Intersect ENT
Research Briefs: Data From Intersect ENT, BioVentrix and Hologic
Acclarent’s Balloon Sinuplasty Device Relieva Heads To Asian Clinics
Companies See Opportunities In Expanding ENT Market
Companies See Opportunities In Expanding ENT Market
Device VCs Choose Flight, And Fight, In Face Of Challenges
Entellus: Helping The Interventional Revolution Balloon In Sinus Therapy
PEAK Cuts Into The Competitive Electrosurgery Market
Device Innovations Target ENT
Acclarent: Can Balloons Open Sinuses and the ENT Device Market?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003761

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel